Clinical trial
A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic…
NCT00321919 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00321919 |
|---|---|
| Title | A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia |
| Official title | A Randomized, Open-label Study of the Effect of NeoRecormon on Reduction of Cardiovascular Risk in Patients With Chronic Renal Anemia Who Are Not on Renal Replacement Therapy. |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia |
| Intervention type | Drug |
| Interventions | epoetin beta [NeoRecormon] |
| Enrollment | 605 |
| Start date | Jul 1, 2000 |
| Primary completion | Oct 1, 2004 |
| Completion | Dec 1, 2004 |
| First posted | May 4, 2006 |
| Last update posted | Jun 29, 2016 |
| Countries | Austria, Belgium, Czechia, Denmark, Finland, France, Germany, Greece, Hong Kong, Ireland, Italy, Mexico and 10 more |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: